The Allstate Corporation (ALL) — Valuation Snapshot
Updated Sep 3, 2026 · bank / insurer · relative-multiples view · descriptive, not a DCF, not advice
The Allstate Corporation (ALL) is a bank, insurer or other financial, and a free-cash-flow discounted-cash-flow (DCF) model is structurally the wrong lens for it: for these businesses debt and float are raw material, not financing, so there is no meaningful 'free cash flow' to discount. Instead of a misleading intrinsic-value number, this page reads ALL the way financials are actually valued — on relative multiples such as price-to-earnings and, above all, price-to-book — plus a plain description of where the stock trades. It is a descriptive snapshot, not a valuation, and not investment advice.
On the numbers we do have, ALL trades at a recent price of $259.34, a market capitalisation of about $65,576,181,760, sitting 80% of the way up its 52-week range ($188.08–$277.22), on the NYSE.
The standard alternative to a DCF is relative valuation — comparing ALL's trading multiples against its direct industry peers. Here that gives P/E of 5.2× (cheaper than the peer median of 12.0×); Fwd P/E of 9.4× (cheaper than the peer median of 11.7×); P/B of 2.1× (in line with the peer median of 2.2×); P/S of 0.9× (cheaper than the peer median of 1.5×); EV/EBITDA of 4.1× (cheaper than the peer median of 8.8×); Dividend yield of 1.7% (cheaper than the peer median of 1.4%). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.
The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. ALL shows a price-to-book (P/B) of 2.08 and book value of $124.79 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.
Finally, a price-based read — explicitly not a valuation. ALL is in an up-trend (price above both its 50- and 200-day averages), trading -6.4% from its 52-week high. Over the past year the stock is +26.1%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.
To be exact about what this page is not: we are not saying the numbers for ALL are unavailable. They are, and they are above. We are saying a discounted-cash-flow model is the wrong instrument for this kind of business, and publishing one anyway — because the inputs happen to exist — would be a precise answer to the wrong question. Refusing is the more useful answer, and it is the same rule we apply to every name in this category.
Relative valuation — ALL vs peers
| Multiple | ALL | Peer median | |
|---|---|---|---|
| P/E | 5.2× | 12.0× | cheaper than |
| Fwd P/E | 9.4× | 11.7× | cheaper than |
| P/B | 2.1× | 2.2× | in line with |
| P/S | 0.9× | 1.5× | cheaper than |
| EV/EBITDA | 4.1× | 8.8× | cheaper than |
| Dividend yield | 1.7% | 1.4% | cheaper than |
Direct industry peers.
Asset / book-value view
Price-to-book compares the market price to the accounting net-asset value per share. Most useful for asset-heavy businesses, banks and insurers.
Price-based snapshot
Price-based, not a valuation. Moving-average trend and 52-week position describe where the stock has traded — they say nothing about fair value.
Compare ALL with its peers
Companies people research alongside ALL
Explore more
Most undervalued stocks (per our valuation) · All valued stocks · Interactive ALL viewA descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is an educational tool, not a licensed investment adviser. Figures are estimates derived from public market data and can be wrong, stale or incomplete.